Douglas R. Morton
Direttore/Membro del Consiglio presso Tetra Therapeutics Inc.
Profilo
Dr. Douglas R.
Morton, Jr. PhD, is Chairman at Hopen Life Sciences LLC, a Principal at Entec UK Ltd., an Advisor at Cleveland Clinic Innovations, and Finance at City of Charlottetown.
He is on the Board of Directors at NephRx Corp.
Dr. Morton is a consultant in the life sciences arena, working with a variety of for-profit and non-profit organizations.
From 2003 to 2006, he was CEO, Southwest Michigan Innovation Center, an incubator/accelerator located in Kalamazoo, MI that provides wet-laboratory space, access to venture funding and business services to emerging companies in the life sciences arena.
Since 2006, he has continued his involvement with the Center as a member of its Managing Directors group.
Doug has wealth of experience in the pharmaceutical industry, joining the Upjohn Company as a research scientist in 1973 and remaining through mergers with Pharmacia AB and Pfizer.
At the time of the Pfizer merger, he was Pharmacia Corporation's Group Vice President, Technology Acquisitions & Operations for Discovery Research.
He previously served on the Board of Directors of TissueInformatics, Inc., Icoria, Inc. (formerly Paradigm Genetics, Inc.) and NanoMed Pharmaceuticals.
Dr. Morton is currently a board member of NephRx Corporation, TCH Pharmaceuticals, Inc., and Tolera Therapeutics, Inc. He is also a member of the Scientific Advisory Board and Management Committee of the Southwest Michigan First Life Science Fund as well as chairman of the Scientific Advisory Board of Metabolic Solutions Development Company.
He is a member of the Industrial Advisory Board of Cleveland Clinic Foundation Innovations.
Dr. Morton holds an AB degree (chemistry) from Kenyon College and a PhD degree in Organic Chemistry from Columbia University.
He completed postdoctoral studies in organic chemistry at Stanford University.
Posizioni attive di Douglas R. Morton
| Società | Posizione | Inizio |
|---|---|---|
Tetra Therapeutics Inc.
 Tetra Therapeutics Inc. BiotechnologyHealth Technology Tetra Therapeutics engages in the development of therapeutic products for neurological disorders. The firm offers BPN14770 PDE4D Inhibitor and PDE4B Inhibitor products. The company was founded by Mark E. Gurney in 2011 and is headquartered in Grand Rapids, MI. | Direttore/Membro del Consiglio | - |
Renovo Neural, Inc.
 Renovo Neural, Inc. BiotechnologyHealth Technology Renovo Neural, Inc. provides preclinical contract research services specializing in neuroscience. Its services include cell-based assays, MS animal models, PD animal models, three dimensional electron microscopy, standard and customized histology, preclinical magnetic resonance imaging, and image analysis. The company was founded by Bruce Trapp in 2008 and is headquartered in Cleveland, OH. | Direttore/Membro del Consiglio | - |
Hopen Life Sciences LLC
 Hopen Life Sciences LLC Investment ManagersFinance Hopen Life Sciences LLC(Hopen Life Sciences) is a venture capital firm founded in 2006 by Mark P. Olesnavage and Jerry Callahan. The firm is headquartered in Grand Rapids, Michigan. | Consulente / Consigliere | - |
Precedenti posizioni note di Douglas R. Morton
| Società | Posizione | Fine |
|---|---|---|
Tolera Therapeutics, Inc.
 Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tolera Therapeutics, Inc. develops novel therapies and technologies for immune modulation. Its products include anti-aßTCR antibody an immune induction therapy in solid organ transplantation and graft versus host disease. The company was founded by Jake Orville, Maria Siemionow, James J. Herrmann and John J. Puisis in 2007 and is headquartered in Ann Arbor, MI. | Direttore/Membro del Consiglio | 25/08/2012 |
| The Upjohn Co. | Corporate Officer/Principal | - |
| Discovery Research | Corporate Officer/Principal | - |
NephRx Corp.
 NephRx Corp. BiotechnologyHealth Technology NephRx Corp. provides therapeutic products for the treatment of kidney failures. The firm's flagship product includes NX001 is a kidney growth factor peptide for acute renal failure that is currently in preclinical development for treatment of delayed graft function in transplant patients. The company was founded in 2001 by Pratik Shah and is headquartered in Kalamazoo, Michigan. | Direttore/Membro del Consiglio | - |
Wood Environment & Infrastructure Solutions UK Ltd.
 Wood Environment & Infrastructure Solutions UK Ltd. Miscellaneous Commercial ServicesCommercial Services Wood Environment & Infrastructure Solutions UK Ltd. provides environmental and engineering consultancy services. The company was founded on November 9, 1987 and is headquartered in Knutsford, the United Kingdom. | Direttore/Membro del Consiglio | 23/07/2009 |
Formazione di Douglas R. Morton
| Kenyon College | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Stanford University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Cogenics Icoria, Inc.
 Cogenics Icoria, Inc. Miscellaneous Commercial ServicesCommercial Services Cogenics Icoria, Inc. provides medical research services. The firm offers genomics and proteomics-related research instruments, consumables, data, including databases, software & other research-oriented products. Icoria offers gene expression analysis and other related services. Its tissue informatics software performs tissue analysis for toxicology studies of early-stage drug candidates and other purposes. The firm also provides biomarkers to develop diagnostics and therapies for liver injuries, metabolic conditions & cancer. The company is headquartered in Research Triangle Park, NC. | Commercial Services |
TissueInformatics, Inc.
 TissueInformatics, Inc. Packaged SoftwareTechnology Services TissueInformatics, Inc. engages in the development and application of TissueAnalytics, automated pathology software. It develops automated pathology software for the quantitative analysis of tissue changes in drug discovery, disease assessment, toxicology, and tissue engineering. The company is headquartered in Pittsburgh, PA. | Technology Services |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
Tolera Therapeutics, Inc.
Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tolera Therapeutics, Inc. develops novel therapies and technologies for immune modulation. Its products include anti-aßTCR antibody an immune induction therapy in solid organ transplantation and graft versus host disease. The company was founded by Jake Orville, Maria Siemionow, James J. Herrmann and John J. Puisis in 2007 and is headquartered in Ann Arbor, MI. | Commercial Services |
Wood Environment & Infrastructure Solutions UK Ltd.
Wood Environment & Infrastructure Solutions UK Ltd. Miscellaneous Commercial ServicesCommercial Services Wood Environment & Infrastructure Solutions UK Ltd. provides environmental and engineering consultancy services. The company was founded on November 9, 1987 and is headquartered in Knutsford, the United Kingdom. | Commercial Services |
NephRx Corp.
NephRx Corp. BiotechnologyHealth Technology NephRx Corp. provides therapeutic products for the treatment of kidney failures. The firm's flagship product includes NX001 is a kidney growth factor peptide for acute renal failure that is currently in preclinical development for treatment of delayed graft function in transplant patients. The company was founded in 2001 by Pratik Shah and is headquartered in Kalamazoo, Michigan. | Health Technology |
| Discovery Research | |
| The Upjohn Co. | Health Technology |
Tetra Therapeutics Inc.
Tetra Therapeutics Inc. BiotechnologyHealth Technology Tetra Therapeutics engages in the development of therapeutic products for neurological disorders. The firm offers BPN14770 PDE4D Inhibitor and PDE4B Inhibitor products. The company was founded by Mark E. Gurney in 2011 and is headquartered in Grand Rapids, MI. | Health Technology |
Renovo Neural, Inc.
Renovo Neural, Inc. BiotechnologyHealth Technology Renovo Neural, Inc. provides preclinical contract research services specializing in neuroscience. Its services include cell-based assays, MS animal models, PD animal models, three dimensional electron microscopy, standard and customized histology, preclinical magnetic resonance imaging, and image analysis. The company was founded by Bruce Trapp in 2008 and is headquartered in Cleveland, OH. | Health Technology |
Hopen Life Sciences LLC
Hopen Life Sciences LLC Investment ManagersFinance Hopen Life Sciences LLC(Hopen Life Sciences) is a venture capital firm founded in 2006 by Mark P. Olesnavage and Jerry Callahan. The firm is headquartered in Grand Rapids, Michigan. | Finance |
- Borsa valori
- Insiders
- Douglas R. Morton
